🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
This is a treatment guideline to allow routine clinical data to be collecte...
Status
Terminated
Location
Masonic Cancer Center, University of Minnesota
Start Date
2013-01
Trial ID
NCT01685411
This research study is assessing the feasibility of reduced intensity allog...
Status
Withdrawn
Location
Massachusetts General Hospital
Start Date
2017-05
Trial ID
NCT02724904
Treatments Being Tested
RATIONALE: Giving low doses of chemotherapy, such as melphalan and fludarab...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2001-07
Trial ID
NCT00027560
RATIONALE: Giving chemotherapy and total body irradiation before a donor bo...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2001-08
Trial ID
NCT00028730
This study is designed to test the ability to achieve donor hematopoietic e...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
2012-07-11
Trial ID
NCT01626092
This study proposes the use of a reduced intensity chemotherapy/radiation t...
Status
Completed
Location
Columbia University Medical Center
Start Date
2002-09
Trial ID
NCT01019876
RATIONALE: Rasburicase may be an effective treatment for graft-versus-host ...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2008-01
Trial ID
NCT00513474
RATIONALE: Antiviral agents are drugs that act against viruses and may be a...
Status
Withdrawn
Location
Duke Comprehensive Cancer Center
Start Date
1998-05
Trial ID
NCT00003435
Our primary objective is to determine if it is feasible for SAA patients to...
Status
Completed
Location
The Sidney Kimmel Comprehensive Cancer Center
Start Date
2014-08
Trial ID
NCT02224872